+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
From
Dermatology OTC Medications Market Report 2025 - Product Thumbnail Image

Dermatology OTC Medications Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Kidney Transplant Market Report 2025 - Product Thumbnail Image

Kidney Transplant Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Vulvodynia Treatment Market Report 2025 - Product Thumbnail Image

Vulvodynia Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Ankylosing Spondylitis Market Report 2025 - Product Thumbnail Image

Ankylosing Spondylitis Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetes - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 450 Pages
  • Global
From
Nontuberculous Mycobacterial Infections Market 2024-2028 - Product Thumbnail Image

Nontuberculous Mycobacterial Infections Market 2024-2028

  • Report
  • December 2023
  • 177 Pages
  • Global
From
From
Opioid Related Disorder - Pipeline Insight, 2025 - Product Thumbnail Image

Opioid Related Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
From
Loading Indicator